Maxigen Biotech Inc.
1783.TW
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.42B
Close$
Share Statistics
| Market cap | $3.42 Billion |
|---|---|
| Enterprise Value | $2.79 Billion |
| Dividend Yield | $2.00 (5.25%) |
| Earnings per Share | $2.96 |
| Beta | 0.17 |
| Outstanding Shares | 53,830,000 |
Return
| Return on Equity | 19.43% |
|---|---|
| Return on Assets | 14.32% |
| Return on Invested Capital | 17.83% |
Valuation & Multiples
| P/E Ratio | 9.92 |
|---|---|
| PEG | 28.98 |
| Price to Sales | 2.54 |
| Price to Book Ratio | 1.41 |
| Enterprise Value to Revenue | 3.33 |
| Enterprise Value to EBIT | 10.39 |
| Enterprise Value to Net Income | 9 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Maxigen Biotech Inc.
127 employees
CEO: Ching-Ting Chen Maxigen Biotech Inc. (MBI) is a company dedicated to the research, development, production, and global commercialization of advanced biomedical and skincare solutions. Its extensive biomedical portfolio includes various orthopedic produc...